We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CHWY Is Leveraging AI & Automation to Enhance Operational Efficiency
Read MoreHide Full Article
Key Takeaways
Chewy is scaling AI across customer service, pharmacy, fulfillment and marketing workflows.
CHWY expects AI initiatives to deliver efficiency gains in the low tens of millions of dollars in fiscal 2026.
Chewy reported 90 basis points of year-over-year SG&A leverage, aided by productivity and early AI benefits.
Chewy, Inc. (CHWY - Free Report) is expanding the use of artificial intelligence ("AI") and automation across its business to enhance customer service and improve operational efficiency. During the first quarter of fiscal 2026, the company built the infrastructure required to deploy AI at scale and began integrating these capabilities across multiple functions to support its long-term growth strategy.
Chewy is applying AI and automation across customer service, pharmacy operations, fulfillment and marketing workflows. Management noted that these initiatives are helping lower the cost of serving customers by improving workflow speed, service quality and productivity. The company is utilizing AI to enhance search relevance, personalization and marketing effectiveness.
Chewy expects AI-driven initiatives to generate efficiency benefits in the low tens of millions of dollars during fiscal 2026, with a more meaningful contribution anticipated in 2027 and beyond. In the first quarter, the company delivered roughly 90 basis points of year-over-year SG&A leverage, supported by fulfillment productivity gains, operating discipline and early benefits from technology, automation and AI-enabled initiatives.
At the same time, Chewy continues to invest in strategic growth initiatives, including expanding Chewy Health, scaling Chewy Vet Care, optimizing its fulfillment network and strengthening customer acquisition capabilities. Management emphasized that investments in AI infrastructure and automation are designed not only to improve near-term productivity but also to reinforce the company's long-term competitive positioning.
Looking ahead, management believes continued investments across health, AI, automation, fulfillment and customer experience will strengthen the Chewy ecosystem. The company reiterated the long-term adjusted EBITDA margin target of 10%, reflecting confidence in the operating model as it balances innovation, automation and disciplined execution.
CHWY’s Price Performance, Valuation & Estimates
Chewy, which competes with BARK, Inc. (BARK - Free Report) and Petco Health and Wellness Company, Inc. (WOOF - Free Report) , has fallen 28% over the past three months against the industry’s growth of 5.5%. Meanwhile, BARK's shares have declined 5.4% and Petco has dipped 1%.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a trailing price-to-sales ratio of 0.63X, below the industry’s average of 2.10X. It has a Value Score of A. CHWY is trading at a premium to BARK (with a trailing 12-month P/S ratio of 0.21) and Petco (0.13).
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CHWY’s fiscal 2026 and 2027 earnings implies year-over-year growth of 20.5% and 21.9%, respectively. Estimates for fiscal 2026 and 2027 have been revised downward by 9 cents and 13 cents, respectively, over the past 30 days.
Image Source: Zacks Investment Research
Although the company continues to invest in AI, healthcare and fulfillment capabilities to support long-term growth, short-term challenges remain. Management expects margin expansion to moderate amid difficult comparisons, higher transportation-related costs and continued strategic investments. A softer consumer spending environment and a more cautious outlook for discretionary categories could limit revenue growth and operating leverage in the near term. CHWY currently carries a Zacks Rank #5 (Strong Sell).
View the Zacks #1 Rank List
Image: Bigstock
CHWY Is Leveraging AI & Automation to Enhance Operational Efficiency
Key Takeaways
Chewy, Inc. (CHWY - Free Report) is expanding the use of artificial intelligence ("AI") and automation across its business to enhance customer service and improve operational efficiency. During the first quarter of fiscal 2026, the company built the infrastructure required to deploy AI at scale and began integrating these capabilities across multiple functions to support its long-term growth strategy.
Chewy is applying AI and automation across customer service, pharmacy operations, fulfillment and marketing workflows. Management noted that these initiatives are helping lower the cost of serving customers by improving workflow speed, service quality and productivity. The company is utilizing AI to enhance search relevance, personalization and marketing effectiveness.
Chewy expects AI-driven initiatives to generate efficiency benefits in the low tens of millions of dollars during fiscal 2026, with a more meaningful contribution anticipated in 2027 and beyond. In the first quarter, the company delivered roughly 90 basis points of year-over-year SG&A leverage, supported by fulfillment productivity gains, operating discipline and early benefits from technology, automation and AI-enabled initiatives.
At the same time, Chewy continues to invest in strategic growth initiatives, including expanding Chewy Health, scaling Chewy Vet Care, optimizing its fulfillment network and strengthening customer acquisition capabilities. Management emphasized that investments in AI infrastructure and automation are designed not only to improve near-term productivity but also to reinforce the company's long-term competitive positioning.
Looking ahead, management believes continued investments across health, AI, automation, fulfillment and customer experience will strengthen the Chewy ecosystem. The company reiterated the long-term adjusted EBITDA margin target of 10%, reflecting confidence in the operating model as it balances innovation, automation and disciplined execution.
CHWY’s Price Performance, Valuation & Estimates
Chewy, which competes with BARK, Inc. (BARK - Free Report) and Petco Health and Wellness Company, Inc. (WOOF - Free Report) , has fallen 28% over the past three months against the industry’s growth of 5.5%. Meanwhile, BARK's shares have declined 5.4% and Petco has dipped 1%.
Image Source: Zacks Investment Research
From a valuation standpoint, CHWY trades at a trailing price-to-sales ratio of 0.63X, below the industry’s average of 2.10X. It has a Value Score of A. CHWY is trading at a premium to BARK (with a trailing 12-month P/S ratio of 0.21) and Petco (0.13).
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for CHWY’s fiscal 2026 and 2027 earnings implies year-over-year growth of 20.5% and 21.9%, respectively. Estimates for fiscal 2026 and 2027 have been revised downward by 9 cents and 13 cents, respectively, over the past 30 days.
Image Source: Zacks Investment Research
Although the company continues to invest in AI, healthcare and fulfillment capabilities to support long-term growth, short-term challenges remain. Management expects margin expansion to moderate amid difficult comparisons, higher transportation-related costs and continued strategic investments. A softer consumer spending environment and a more cautious outlook for discretionary categories could limit revenue growth and operating leverage in the near term. CHWY currently carries a Zacks Rank #5 (Strong Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.